Täby, 22 December, 2014 - Mycronic AB (publ), today adjusts the outlook upwards
for full year sales in 2014.
The current assessment for sales in 2014 has been in the span of SEK 1,150 –
1,250 million. Sales within both business areas, SMT and PG, is developing above
expectations and the company
is now making an adjustment upwards of full year sales in 2014.
The company´s new assessment is that sales in 2014 will be approximately SEK
1,440 million.
“In September, 2014 we received an order for a Pexision-80 mask writer for cost
-effective manufacturing of the most advanced photomasks for display
applications. At the time of the order, delivery was expected during the first
quarter in 2015”, says Lena Olving, President and CEO of Mycronic AB.
“Completion of the newly developed machine has been faster than planned and we
have agreed to send the machine to our customer already by the end of this year.
The P-80 delivery is the main reason for the upwards adjustment of 2014 full
year sales assessment.”
Contacts at Mycronic:
Lena Olving
President and CEO
Tel: +46 8 638 52 00
lena.olving@mycronic.com
Per Ekstedt
CFO
Tel: +46 8 638 52 00
per.ekstedt@mycronic.com
About Mycronic AB
Mycronic AB is a Swedish high-tech company engaged in the development,
manufacture and marketing of production equipment to the electronics industry.
Mycronic headquarters is located in Täby, north of Stockholm and the Group has
subsidiaries in China, France, Germany Japan, Singapore, South Korea, Taiwan,
the Netherlands, United Kingdom and the United States. For more information see
our web site at: www.mycronic.com
Mycronic AB (publ) is listed on NASDAQ Stockholm, Small Cap: MYCR.
The information is of the type that Mycronic is required to disclose under the
Financial Instruments trading Act and/or the Swedish Securities Markets Act. The
information was submitted for publication on 22 December, 2014.
